CPChao Peng

Chao Peng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chao Peng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Cailiang Shen

    Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, 230032, Hefei, China

    1 shared publication
  • Chen Kan

    Anhui Medical University, Hefei

    1 shared publication
  • Chenghang Zhu

    Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, 230022, Hefei, China

    1 shared publication
  • Hailin Wang

    Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, 230022, Hefei, China

    1 shared publication
  • Haitao Fan

    Department of Orthopedics, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, 315010, Ningbo, China.

    1 shared publication
  • Hong Zheng

    Department of Pathophysiology, Anhui Medical University, Hefei, China

    1 shared publication

Latest Publications

  • Open Access

    GNAS/PKA signaling promotes aberrant osteochondral differentiation of Gli1+ tendon sheath progenitors

    by Lijun Chen, Chao Peng, Lanyi Chai, Renjie Zhang, Chenghang Zhu, Hailin Wang, Qirong Cheng, Yan Yan, Cailiang Shen, Hong Zheng, et al.

    Tendon injury promotes aberrant osteochondral differentiation of tendon stem cells (TSCs) and results in disability. However, the cellular subsets within the osteochondral lineage involved in this process and associated mechanisms remain unclear. Here, we found that, following Achilles tenotomy, murine Gli1 + tendon sheath cells expanded rapidly, transitioning into tenogenic and osteochondrogenic cells. Lineage tracing, together with single-cell RNA sequencing, revealed that osteochondrogenic Gli1 + tendon sheath cells originate from Scx + tendon stem/progenitor cells, preferentially differentiate into osteochondral lineage tendon progenitors at 7 dpi, subsequently undergoing aberrant chondrogenesis and osteogenesis at 21dpi and 63dpi, respectively. In addition, Acvr1 R206H/+ robustly accelerates osteochondral differentiation in Gli1 + tendon sheath progenitors. Furthermore, GNAS/PKA signaling was significantly activated in osteochondral differentiation of Gli1 + tendon sheath progenitors. Alternatively, treatment with the G sα antagonist, NF449, or genetic inhibition of the PKA subunit, Prkaca , in Gli1 + sheath progenitors significantly alleviated aberrant osteochondral differentiation. NF449 also prevented osteochondral differentiation of human tendon stem cells. These findings identify Gli1 + tendon sheath progenitors with osteochondral differentiation capacity during heterotopic ossification via activation of GNAS/PKA signaling, suggesting PKA as a potentially effective therapeutic target to treat tendon ossification.